Join Sharmila Nebhrajani OBE, Chair of NICE, as she delves into the monumental changes ahead for healthcare. From tackling the 'postcode lottery' to embracing cutting-edge digital technologies and AI.... Read more! 👇 ow.ly/LBCL50S3We7

We're updating our guideline on recurrent urinary tract infections, with the consultation draft open until September 12⬇️ nice.org.uk/guidance/indev… It includes new recommendations on methenamine hippurate as an alternative to daily preventative antibiotics. #NICENews

New treatment option for #gastriccancer recommended, with more than a thousand people set to benefit from pembrolizumab with chemotherapy. Find out more⤵️ nice.org.uk/guidance/ta997… #NICENews

We’re inviting healthtech and pharmaceutical developers to join us for a free NICE Advice webinar. Learn about our guidance topic priorities for 2024/25 and beyond, and the implications for the life sciences sector⬇️ meetnice.zoom.us/webinar/regist…

Health and care professionals, stay updated with NICE's latest guidelines via our new WhatsApp updates channel. 📲 On mobile? Join here: whatsapp.com/channel/0029Va… 🖥 On desktop? Scan the QR code in the video 🔔Once subscribed hit the bell to stay notified.

"It feels like you've given me a new pancreas." Diagnosed with #T1Diabetes at 22, Ammaarah had constant migraines and disrupted sleep. Life changed when she received a NICE-recommended hybrid closed loop system, often called an 'artificial pancreas.' 🔗indepth.nice.org.uk/TA943PatientsS…

Around 330,000 adults with overactive bladder syndrome could be set to benefit after we recommended Vibegron, a new daily pill, in final guidance today. Find out more⤵️ nice.org.uk/guidance/indev… #NICENews

We'll help you cut through complexity, navigating the right path to NHS access⤵️ nice.org.uk/about/what-we-…

First treatment for marginal zone lymphoma after anti-CD20-based treatment, recommended by NICE in final guidance. Zanubrutinib is a pill treatment, providing a more convenient option than current standard care. Find out more: nice.org.uk/guidance/ta100…

People with advanced #thyroidcancer could be set to benefit from a new treatment recommended today. Our independent advisory committee has recommended selpercatinib in final draft guidance. Learn more:nice.org.uk/guidance/indev… #NICENews

What are the challenges and opportunities for NICE over the next 25 years? Hear the thoughts from our partners in the system ⤵ youtube.com/watch?v=RRDz04… #NICE25

⏰#NICEConf2025 early bird discount ends 15 September. The conference will bring frontline staff and leaders from health and care together with the life sciences, healthtech and digital sectors. 📅 Register now to join us in Manchester on 27 March: bit.ly/NICEConfregX

Join us online to hear from NICE’s Deputy CEO, Jonathan Benger, on how we are refining our HST programme. Learn how these changes will enhance transparency, consistency, and access to treatments for very #RareDiseases. Register here: eventbrite.co.uk/e/reviewing-an…

🔊 Listen to the latest news bulletin from National #Health Executive ⬇️ 🚨 NHS mental health: Charity calls for increased #prevention funding 🚨 NICE makes two landmark approvals 🚨 #NHS CEO Amanda Pritchard makes armed forces pledge For more details on all our stories, check

Find out about our priorities and work in health and social care at our next virtual public board meeting. Wed 25 Sept (1:30pm-4pm) Register here⬇️ nice.org.uk/event/pbseptem…